These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29310467)

  • 1. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents.
    Hajipour H; Nouri M; Ghorbani M; Bahramifar A; Emameh RZ; Taheri RA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Dec; 394(12):2353-2362. PubMed ID: 34522984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
    Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
    Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
    Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil citrate-loaded targeted nanostructured lipid carrier enhances receptivity potential of endometrial cells via LIF and VEGF upregulation.
    Hajipour H; Sambrani R; Ghorbani M; Mirzamohammadi Z; Nouri M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2323-2331. PubMed ID: 34515834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
    Frias I; Neves AR; Pinheiro M; Reis S
    Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
    Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
    Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
    Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
    Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
    Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
    Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
    Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
    Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
    J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
    Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
    Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
    Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
    Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
    Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
    Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage.
    Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S
    Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.